Aileen L. Pangan
- Rheumatology top 0.1%
- Immunology top 1%
- Hematology top 0.5%
- Oncology top 5%
- Dermatology top 0.5%
- Co-authors
- Joachim SieperDésirée van der HeijdePhilip J. MeaseYijie ZhouWalter P. MaksymowychFilip Van den BoschHeidi S. CampMohamed I. A. Othman
- Topics
- Rheumatoid Arthritis Research and Therapies (53 papers)Spondyloarthritis Studies and Treatments (40 papers)Autoimmune and Inflammatory Disorders Research (38 papers)
- Cited by
- RheumatologyHematologyImmunology
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Aileen L. Pangan
93 papers receiving 5.3k citations
Hit Papers
Peers
Comparison fields: 5 of 93
- Rheumatology 4.0k
- Immunology 2.0k
- Hematology 2.0k
- Oncology 767
- Dermatology 722
Countries citing papers authored by Aileen L. Pangan
This map shows the geographic impact of Aileen L. Pangan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aileen L. Pangan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aileen L. Pangan more than expected).
Fields of papers citing papers by Aileen L. Pangan
This network shows the impact of papers produced by Aileen L. Pangan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aileen L. Pangan. The network helps show where Aileen L. Pangan may publish in the future.
Co-authorship network of co-authors of Aileen L. Pangan
This figure shows the co-authorship network connecting the top 25 collaborators of Aileen L. Pangan. A scholar is included among the top collaborators of Aileen L. Pangan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aileen L. Pangan. Aileen L. Pangan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 79 | |
| 2 | 4 | |
| 3 | 20 | |
| 4 | 15 | |
| 5 | 4 | |
| 6 | 162 | |
| 7 | Upadacitinib in adults with moderate to severe atopic dermatitis: 16-week results from a randomized, placebo-controlled trialbreakdown → | 255 |
| 8 | 242 | |
| 9 | Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 studybreakdown → | 260 |
| 10 | 70 | |
| 11 | 21 | |
| 12 | 50 | |
| 13 | 42 | |
| 14 | 12 | |
| 15 | 24 | |
| 16 | 4 | |
| 17 | 55 | |
| 18 | 73 | |
| 19 | 159 | |
| 20 | 47 |
About Aileen L. Pangan
Aileen L. Pangan is a scholar working on Rheumatology, Hematology and Immunology, having authored 94 papers that have together received 5.4k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (53 papers), Spondyloarthritis Studies and Treatments (40 papers) and Autoimmune and Inflammatory Disorders Research (38 papers). The work is most often cited by research in Rheumatology (4.0k citations), Hematology (2.0k citations) and Immunology (2.0k citations). Aileen L. Pangan has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Joachim Sieper, Désirée van der Heijde, Philip J. Mease, Yijie Zhou, Walter P. Maksymowych, Filip Van den Bosch, Heidi S. Camp, Mohamed I. A. Othman, J. Anderson and Mark C. Genovese. Their work appears in journals such as New England Journal of Medicine, The Lancet and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.